152 related articles for article (PubMed ID: 27983531)
1. PFKFB3 was overexpressed in gastric cancer patients and promoted the proliferation and migration of gastric cancer cells.
Han J; Meng Q; Xi Q; Wang H; Wu G
Cancer Biomark; 2017; 18(3):249-256. PubMed ID: 27983531
[TBL] [Abstract][Full Text] [Related]
2. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
[TBL] [Abstract][Full Text] [Related]
3. A Potential Oncogenic Role for PFKFB3 Overexpression in Gastric Cancer Progression.
Lei L; Hong LL; Ling ZN; Zhong Y; Hu XY; Li P; Ling ZQ
Clin Transl Gastroenterol; 2021 Jul; 12(7):e00377. PubMed ID: 34193800
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA MSC-AS1 facilitates the proliferation and glycolysis of gastric cancer cells by regulating PFKFB3 expression.
Jin X; Qiao L; Fan H; Liao C; Zheng J; Wang W; Ma X; Yang M; Sun X; Zhao W
Int J Med Sci; 2021; 18(2):546-554. PubMed ID: 33390824
[TBL] [Abstract][Full Text] [Related]
5. Hyperglycemia induces miR-26-5p down-regulation to overexpress PFKFB3 and accelerate epithelial-mesenchymal transition in gastric cancer.
He X; Cheng X; Ding J; Xiong M; Chen B; Cao G
Bioengineered; 2022 Feb; 13(2):2902-2917. PubMed ID: 35094634
[TBL] [Abstract][Full Text] [Related]
6. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
[TBL] [Abstract][Full Text] [Related]
7. Expression of Reg IV and SOX9 and their correlation in human gastric cancer.
Zhang N; Chai D; Du H; Li K; Xie W; Li X; Yang R; Lian X; Xu Y
BMC Cancer; 2018 Mar; 18(1):344. PubMed ID: 29587675
[TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor as a potential prognostic factor in gastric cancer.
He LJ; Xie D; Hu PJ; Liao YJ; Deng HX; Kung HF; Zhu SL
World J Gastroenterol; 2015 Sep; 21(34):9916-26. PubMed ID: 26379396
[TBL] [Abstract][Full Text] [Related]
9. Hyperglycemia induces PFKFB3 overexpression and promotes malignant phenotype of breast cancer through RAS/MAPK activation.
Cheng X; Jia X; Wang C; Zhou S; Chen J; Chen L; Chen J
World J Surg Oncol; 2023 Mar; 21(1):112. PubMed ID: 36973739
[TBL] [Abstract][Full Text] [Related]
10. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
12. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
13. PFKFB3 Control of Cancer Growth by Responding to Circadian Clock Outputs.
Chen L; Zhao J; Tang Q; Li H; Zhang C; Yu R; Zhao Y; Huo Y; Wu C
Sci Rep; 2016 Apr; 6():24324. PubMed ID: 27079271
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer.
Han J; Meng Q; Xi Q; Zhang Y; Zhuang Q; Han Y; Jiang Y; Ding Q; Wu G
Int J Oncol; 2016 Jan; 48(1):215-24. PubMed ID: 26530697
[TBL] [Abstract][Full Text] [Related]
15. KITENIN is associated with tumor progression in human gastric cancer.
Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
[TBL] [Abstract][Full Text] [Related]
16. Expression of early growth response-1 in human gastric cancer and its relationship with tumor cell behaviors and prognosis.
Myung E; Park YL; Kim N; Chung CY; Park HB; Park HC; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
Pathol Res Pract; 2013 Nov; 209(11):692-9. PubMed ID: 24011795
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of EPHB4 Is Associated with Poor Survival of Patients with Gastric Cancer.
Yin J; Cui Y; Li L; Ji J; Jiang WG
Anticancer Res; 2017 Aug; 37(8):4489-4497. PubMed ID: 28739744
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
Ge X; Lyu P; Cao Z; Li J; Guo G; Xia W; Gu Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):1115-21. PubMed ID: 26093295
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase D3 promotes gastric cancer development through p65/6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 activation of glycolysis.
Zhang J; Zhang Y; Wang J; Zhang S; Zhao Y; Ren H; Chu Y; Feng L; Wang C
Exp Cell Res; 2019 Jul; 380(2):188-197. PubMed ID: 31026442
[TBL] [Abstract][Full Text] [Related]
20.
Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD
World J Gastroenterol; 2016 Dec; 22(47):10364-10370. PubMed ID: 28058016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
